Global Troponin Diagnostic Tests Market

Troponin Diagnostic Tests Comprehensive Study by Type (Troponin I ELISA Test, Troponin Rapid test), Sales Channels (Online Sales Channel {Company Website, E-Commerce Platform}, Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}), Technology (Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI), Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI), Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)) Players and Region - Global Market Outlook to 2030

Troponin Diagnostic Tests Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 11.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Troponin Diagnostic Tests
A troponin test is to measures the level of troponin in blood. A protein found in the muscles of your heart, which isn't normally found in the blood. Troponin is sent into the bloodstream when heart muscles become damaged. This test is most prominently used to diagnose a heart attack. Along with this also used to monitor angina, which limits blood flow to the heart and causes chest pain. It has been estimated that 840,000 Americans die of cardiovascular diseases each year. In 2017 Food and Drug Administration (FDA) approved since then many laboratories in the U.S. used high-sensitivity troponin tests.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR11.2%


Major manufacturers of the products are well-established pharma companies and they are mainly focusing on the research and development of the products like up-gradation of testing kit 4th generation to 5th generation which is more accurate, can detect a fraction of fluctuations in troponin. Although the leading pharma companies focusing on more acquisitions of the small scale companies to reach out. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Troponin Diagnostic Tests market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Diagnostics, Inc. (United States.), F. Hoffmann-La Roche Ltd (Switzerland), BioMrieux SA (France), BG Medicine, Inc. (United States), Singulex, Inc. (United States), Alere, Inc. (United States), Siemens Healthcare Diagnostics, Inc. (Germany), Beckman Coulter, Inc. (United States), LifeSign LLC (United States) and Danaher Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Thermo Fisher Scientific, Inc. (United States), Bio-Rad Laboratories, Inc. (United States) and Ortho-Clinical Diagnostics, Inc. (India).

Segmentation Overview
AMA Research has segmented the market of Global Troponin Diagnostic Tests market by Type (Troponin I ELISA Test and Troponin Rapid test) and Region.



On the basis of geography, the market of Troponin Diagnostic Tests has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channels, the sub-segment i.e. Online Sales Channel {Company Website, E-Commerce Platform} will boost the Troponin Diagnostic Tests market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI) will boost the Troponin Diagnostic Tests market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
High sensitivity troponin test kits products

Market Growth Drivers:
By application, the global troponin market is driven into acute coronary syndrome, myocardial infarction, which is a leading application of troponin

Challenges:
Time taking process creates many challenges to lower-sensitivity troponin assays

Restraints:
Major restraints for troponin diagnostic kits was observed that 68% of test kits used for the diagnosis of physically injured patients, followed by older people

Opportunities:
Developmental opportunities for Troponin diagnostic kits are majorly in prize of the kit, home testing kits and availability of the kit

Market Leaders and their expansionary development strategies
In October 2023, Mediport, a company that provides a service that monitors interstate transport companies, and GE HealthCare, an independent healthcare technology and diagnostics company, inaugurated the first of its kind One-Stop Clinic to serve cardiology patients. Patients visiting the clinic will receive a same-day diagnosis and care plan.
In March 2024, Polymedco received 510(k) clearance from the US Food and Drug Administration (FDA) for its rapid troponin assay as part of its Pathfast Biomarker Analyser. The troponin assay (hs-CTnl-II) detects the presence of cardiac troponin I, an acute change in its concentration is indicative of myocardial infarction. It is a biomarker of choice for diagnosing acute myocardial infarction.


Key Target Audience
Hospitals, Medical Institutes and Pathology Labs

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Troponin I ELISA Test
  • Troponin Rapid test
By Sales Channels
  • Online Sales Channel {Company Website, E-Commerce Platform}
  • Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}

By Technology
  • Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI)
  • Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI)
  • Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. By application, the global troponin market is driven into acute coronary syndrome, myocardial infarction, which is a leading application of troponin
    • 3.3. Market Challenges
      • 3.3.1. Time taking process creates many challenges to lower-sensitivity troponin assays
    • 3.4. Market Trends
      • 3.4.1. High sensitivity troponin test kits products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Troponin Diagnostic Tests, by Type, Sales Channels, Technology and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Troponin Diagnostic Tests (Value)
      • 5.2.1. Global Troponin Diagnostic Tests by: Type (Value)
        • 5.2.1.1. Troponin I ELISA Test
        • 5.2.1.2. Troponin Rapid test
      • 5.2.2. Global Troponin Diagnostic Tests by: Sales Channels (Value)
        • 5.2.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 5.2.2.2. Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}
      • 5.2.3. Global Troponin Diagnostic Tests by: Technology (Value)
        • 5.2.3.1. Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI)
        • 5.2.3.2. Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI)
        • 5.2.3.3. Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)
      • 5.2.4. Global Troponin Diagnostic Tests Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Troponin Diagnostic Tests (Price)
      • 5.3.1. Global Troponin Diagnostic Tests by: Type (Price)
  • 6. Troponin Diagnostic Tests: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Diagnostics, Inc. (United States.)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BioMrieux SA (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BG Medicine, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Singulex, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Alere, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Siemens Healthcare Diagnostics, Inc. (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Beckman Coulter, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LifeSign LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Danaher Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Troponin Diagnostic Tests Sale, by Type, Sales Channels, Technology and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Troponin Diagnostic Tests (Value)
      • 7.2.1. Global Troponin Diagnostic Tests by: Type (Value)
        • 7.2.1.1. Troponin I ELISA Test
        • 7.2.1.2. Troponin Rapid test
      • 7.2.2. Global Troponin Diagnostic Tests by: Sales Channels (Value)
        • 7.2.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 7.2.2.2. Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}
      • 7.2.3. Global Troponin Diagnostic Tests by: Technology (Value)
        • 7.2.3.1. Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI)
        • 7.2.3.2. Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI)
        • 7.2.3.3. Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI)
      • 7.2.4. Global Troponin Diagnostic Tests Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Troponin Diagnostic Tests (Price)
      • 7.3.1. Global Troponin Diagnostic Tests by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Troponin Diagnostic Tests: by Type(USD Million)
  • Table 2. Troponin Diagnostic Tests Troponin I ELISA Test , by Region USD Million (2018-2023)
  • Table 3. Troponin Diagnostic Tests Troponin Rapid test , by Region USD Million (2018-2023)
  • Table 4. Troponin Diagnostic Tests: by Sales Channels(USD Million)
  • Table 5. Troponin Diagnostic Tests Online Sales Channel {Company Website, E-Commerce Platform} , by Region USD Million (2018-2023)
  • Table 6. Troponin Diagnostic Tests Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores} , by Region USD Million (2018-2023)
  • Table 7. Troponin Diagnostic Tests: by Technology(USD Million)
  • Table 8. Troponin Diagnostic Tests Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI) , by Region USD Million (2018-2023)
  • Table 9. Troponin Diagnostic Tests Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI) , by Region USD Million (2018-2023)
  • Table 10. Troponin Diagnostic Tests Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI) , by Region USD Million (2018-2023)
  • Table 11. South America Troponin Diagnostic Tests, by Country USD Million (2018-2023)
  • Table 12. South America Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 13. South America Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 14. South America Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 15. Brazil Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 16. Brazil Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 17. Brazil Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 18. Argentina Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 19. Argentina Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 20. Argentina Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 21. Rest of South America Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 22. Rest of South America Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 23. Rest of South America Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 24. Asia Pacific Troponin Diagnostic Tests, by Country USD Million (2018-2023)
  • Table 25. Asia Pacific Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 26. Asia Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 27. Asia Pacific Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 28. China Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 29. China Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 30. China Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 31. Japan Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 32. Japan Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 33. Japan Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 34. India Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 35. India Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 36. India Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 37. South Korea Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 38. South Korea Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 39. South Korea Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 40. Australia Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 41. Australia Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 42. Australia Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 43. Rest of Asia-Pacific Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 44. Rest of Asia-Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 45. Rest of Asia-Pacific Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 46. Europe Troponin Diagnostic Tests, by Country USD Million (2018-2023)
  • Table 47. Europe Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 48. Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 49. Europe Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 50. Germany Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 51. Germany Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 52. Germany Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 53. France Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 54. France Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 55. France Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 56. Italy Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 57. Italy Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 58. Italy Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 59. United Kingdom Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 60. United Kingdom Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 61. United Kingdom Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 62. Netherlands Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 63. Netherlands Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 64. Netherlands Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 65. Rest of Europe Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 66. Rest of Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 67. Rest of Europe Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 68. MEA Troponin Diagnostic Tests, by Country USD Million (2018-2023)
  • Table 69. MEA Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 70. MEA Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 71. MEA Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 72. Middle East Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 73. Middle East Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 74. Middle East Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 75. Africa Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 76. Africa Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 77. Africa Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 78. North America Troponin Diagnostic Tests, by Country USD Million (2018-2023)
  • Table 79. North America Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 80. North America Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 81. North America Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 82. United States Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 83. United States Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 84. United States Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 85. Canada Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 86. Canada Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 87. Canada Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 88. Mexico Troponin Diagnostic Tests, by Type USD Million (2018-2023)
  • Table 89. Mexico Troponin Diagnostic Tests, by Sales Channels USD Million (2018-2023)
  • Table 90. Mexico Troponin Diagnostic Tests, by Technology USD Million (2018-2023)
  • Table 91. Troponin Diagnostic Tests: by Type(USD/Units)
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Troponin Diagnostic Tests: by Type(USD Million)
  • Table 103. Troponin Diagnostic Tests Troponin I ELISA Test , by Region USD Million (2025-2030)
  • Table 104. Troponin Diagnostic Tests Troponin Rapid test , by Region USD Million (2025-2030)
  • Table 105. Troponin Diagnostic Tests: by Sales Channels(USD Million)
  • Table 106. Troponin Diagnostic Tests Online Sales Channel {Company Website, E-Commerce Platform} , by Region USD Million (2025-2030)
  • Table 107. Troponin Diagnostic Tests Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores} , by Region USD Million (2025-2030)
  • Table 108. Troponin Diagnostic Tests: by Technology(USD Million)
  • Table 109. Troponin Diagnostic Tests Qualitative Cardiac Troponin I Rapid Test (Qualitative cTnI) , by Region USD Million (2025-2030)
  • Table 110. Troponin Diagnostic Tests Semi-Quantitative Cardiac Troponin I Rapid Test (Semi-Quantitative cTnI) , by Region USD Million (2025-2030)
  • Table 111. Troponin Diagnostic Tests Quantitative Cardiac Troponin I Rapid Test (Quantitative cTnI) , by Region USD Million (2025-2030)
  • Table 112. South America Troponin Diagnostic Tests, by Country USD Million (2025-2030)
  • Table 113. South America Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 114. South America Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 115. South America Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 116. Brazil Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 117. Brazil Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 118. Brazil Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 119. Argentina Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 120. Argentina Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 121. Argentina Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 122. Rest of South America Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 123. Rest of South America Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 124. Rest of South America Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 125. Asia Pacific Troponin Diagnostic Tests, by Country USD Million (2025-2030)
  • Table 126. Asia Pacific Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 127. Asia Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 128. Asia Pacific Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 129. China Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 130. China Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 131. China Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 132. Japan Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 133. Japan Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 134. Japan Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 135. India Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 136. India Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 137. India Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 138. South Korea Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 139. South Korea Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 140. South Korea Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 141. Australia Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 142. Australia Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 143. Australia Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 144. Rest of Asia-Pacific Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 145. Rest of Asia-Pacific Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 146. Rest of Asia-Pacific Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 147. Europe Troponin Diagnostic Tests, by Country USD Million (2025-2030)
  • Table 148. Europe Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 149. Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 150. Europe Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 151. Germany Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 152. Germany Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 153. Germany Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 154. France Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 155. France Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 156. France Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 157. Italy Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 158. Italy Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 159. Italy Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 160. United Kingdom Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 161. United Kingdom Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 162. United Kingdom Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 163. Netherlands Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 164. Netherlands Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 165. Netherlands Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 166. Rest of Europe Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 167. Rest of Europe Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 168. Rest of Europe Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 169. MEA Troponin Diagnostic Tests, by Country USD Million (2025-2030)
  • Table 170. MEA Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 171. MEA Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 172. MEA Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 173. Middle East Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 174. Middle East Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 175. Middle East Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 176. Africa Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 177. Africa Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 178. Africa Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 179. North America Troponin Diagnostic Tests, by Country USD Million (2025-2030)
  • Table 180. North America Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 181. North America Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 182. North America Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 183. United States Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 184. United States Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 185. United States Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 186. Canada Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 187. Canada Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 188. Canada Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 189. Mexico Troponin Diagnostic Tests, by Type USD Million (2025-2030)
  • Table 190. Mexico Troponin Diagnostic Tests, by Sales Channels USD Million (2025-2030)
  • Table 191. Mexico Troponin Diagnostic Tests, by Technology USD Million (2025-2030)
  • Table 192. Troponin Diagnostic Tests: by Type(USD/Units)
  • Table 193. Research Programs/Design for This Report
  • Table 194. Key Data Information from Secondary Sources
  • Table 195. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Troponin Diagnostic Tests: by Type USD Million (2018-2023)
  • Figure 5. Global Troponin Diagnostic Tests: by Sales Channels USD Million (2018-2023)
  • Figure 6. Global Troponin Diagnostic Tests: by Technology USD Million (2018-2023)
  • Figure 7. South America Troponin Diagnostic Tests Share (%), by Country
  • Figure 8. Asia Pacific Troponin Diagnostic Tests Share (%), by Country
  • Figure 9. Europe Troponin Diagnostic Tests Share (%), by Country
  • Figure 10. MEA Troponin Diagnostic Tests Share (%), by Country
  • Figure 11. North America Troponin Diagnostic Tests Share (%), by Country
  • Figure 12. Global Troponin Diagnostic Tests: by Type USD/Units (2018-2023)
  • Figure 13. Global Troponin Diagnostic Tests share by Players 2023 (%)
  • Figure 14. Global Troponin Diagnostic Tests share by Players (Top 3) 2023(%)
  • Figure 15. Global Troponin Diagnostic Tests share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Diagnostics, Inc. (United States.) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Diagnostics, Inc. (United States.) Revenue: by Geography 2023
  • Figure 19. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2023
  • Figure 21. BioMrieux SA (France) Revenue, Net Income and Gross profit
  • Figure 22. BioMrieux SA (France) Revenue: by Geography 2023
  • Figure 23. BG Medicine, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. BG Medicine, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Singulex, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Singulex, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Alere, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Alere, Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Siemens Healthcare Diagnostics, Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Siemens Healthcare Diagnostics, Inc. (Germany) Revenue: by Geography 2023
  • Figure 31. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Beckman Coulter, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. LifeSign LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. LifeSign LLC (United States) Revenue: by Geography 2023
  • Figure 35. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Danaher Corporation (United States) Revenue: by Geography 2023
  • Figure 37. Global Troponin Diagnostic Tests: by Type USD Million (2025-2030)
  • Figure 38. Global Troponin Diagnostic Tests: by Sales Channels USD Million (2025-2030)
  • Figure 39. Global Troponin Diagnostic Tests: by Technology USD Million (2025-2030)
  • Figure 40. South America Troponin Diagnostic Tests Share (%), by Country
  • Figure 41. Asia Pacific Troponin Diagnostic Tests Share (%), by Country
  • Figure 42. Europe Troponin Diagnostic Tests Share (%), by Country
  • Figure 43. MEA Troponin Diagnostic Tests Share (%), by Country
  • Figure 44. North America Troponin Diagnostic Tests Share (%), by Country
  • Figure 45. Global Troponin Diagnostic Tests: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Abbott Diagnostics, Inc. (United States.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • BioMrieux SA (France)
  • BG Medicine, Inc. (United States)
  • Singulex, Inc. (United States)
  • Alere, Inc. (United States)
  • Siemens Healthcare Diagnostics, Inc. (Germany)
  • Beckman Coulter, Inc. (United States)
  • LifeSign LLC (United States)
  • Danaher Corporation (United States)
Additional players considered in the study are as follows:
Thermo Fisher Scientific, Inc. (United States) , Bio-Rad Laboratories, Inc. (United States) , Ortho-Clinical Diagnostics, Inc. (India)
Select User Access Type

Key Highlights of Report


Apr 2024 170 Pages 69 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Troponin Diagnostic Tests Market Quantitative research analysis
Global Troponin Diagnostic Tests Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Diagnostics, Inc. (United States.), F. Hoffmann-La Roche Ltd (Switzerland), BioMrieux SA (France), BG Medicine, Inc. (United States), Singulex, Inc. (United States), Alere, Inc. (United States), Siemens Healthcare Diagnostics, Inc. (Germany), Beckman Coulter, Inc. (United States), LifeSign LLC (United States) and Danaher Corporation (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"High sensitivity troponin test kits products" is seen as one of major influencing trends for Troponin Diagnostic Tests Market during projected period 2023-2030.
The Troponin Diagnostic Tests market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Troponin Diagnostic Tests Market Report?

Have a Query? Click Here

Other Related Reports

Tele-Intensive Care Unit Comprehensive Study by Type (Centralized, Decentralized, Other (Hybrid)), (), Component (Hardware (Computer System, Communication Lines, Physiological Monitors, Therapeutic ...
$ 3350
Tissue Diagnostics Comprehensive Study by Type (Consumables(Antibodies Kits, Reagents, Probes), Instruments (Slide Staining System, Scanner)), Application (Breast Cancer, Gastric Cancer, Lymphoma, Pr...
$ 3750
Electroceuticals/Bioelectric Medicine Comprehensive Study by Type (Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Implantable Cardioverter Defibrillators, Deep Brain Stimulators, Transcutane...
$ 3800
Hypopigmentation Disorder Treatment Comprehensive Study by Type (Topical Drugs, Laser, Chemical Peels, Microdermabrasion, Others), Application (Vitiligo, Albinism, Others), End-Use (Hospitals, Aesthe...
$ 3350
Medical Device Security Comprehensive Study by Type (Application Security, Endpoint Security, Network Security, Cloud Security, Other Security Types (Email, Web, and Database Security)), Application ...
$ 3750
Renal Biomarker Comprehensive Study by Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers), Application (Hospital, Diagnostic Laboratory, Other), Di...
$ 3750